SLNO logo

Soleno Therapeutics (SLNO) Company Overview

Profile

Full Name:

Soleno Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 13, 2014

Indexes:

Not included

Description:

SLNO (Soleno Therapeutics) is a biopharmaceutical company focused on developing innovative treatments for rare diseases, particularly those related to metabolic disorders. Their lead product aims to improve the lives of patients with specific genetic conditions by targeting underlying biological mechanisms.

Events Calendar

Earnings

Next earnings date:

Aug 7, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 21, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 26, 2022

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Dec 2, 24 HC Wainwright & Co.
Buy
Dec 2, 24 Baird
Outperform
Nov 11, 24 HC Wainwright & Co.
Buy
Oct 28, 24 Oppenheimer
Outperform
Aug 12, 24 Oppenheimer
Outperform
Jul 31, 24 Cantor Fitzgerald
Overweight
May 13, 24 Oppenheimer
Outperform
May 10, 24 Baird
Outperform
Feb 5, 24 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Soleno Therapeutics?
  • Does Soleno Therapeutics pay dividends?
  • What sector is Soleno Therapeutics in?
  • What industry is Soleno Therapeutics in?
  • What country is Soleno Therapeutics based in?
  • When did Soleno Therapeutics go public?
  • Is Soleno Therapeutics in the S&P 500?
  • Is Soleno Therapeutics in the NASDAQ 100?
  • Is Soleno Therapeutics in the Dow Jones?
  • When was Soleno Therapeutics's last earnings report?
  • When does Soleno Therapeutics report earnings?
  • Should I buy Soleno Therapeutics stock now?

What is the ticker symbol for Soleno Therapeutics?

The ticker symbol for Soleno Therapeutics is NASDAQ:SLNO

Does Soleno Therapeutics pay dividends?

No, Soleno Therapeutics does not pay dividends

What sector is Soleno Therapeutics in?

Soleno Therapeutics is in the Healthcare sector

What industry is Soleno Therapeutics in?

Soleno Therapeutics is in the Biotechnology industry

What country is Soleno Therapeutics based in?

Soleno Therapeutics is headquartered in United States

When did Soleno Therapeutics go public?

Soleno Therapeutics's initial public offering (IPO) was on November 13, 2014

Is Soleno Therapeutics in the S&P 500?

No, Soleno Therapeutics is not included in the S&P 500 index

Is Soleno Therapeutics in the NASDAQ 100?

No, Soleno Therapeutics is not included in the NASDAQ 100 index

Is Soleno Therapeutics in the Dow Jones?

No, Soleno Therapeutics is not included in the Dow Jones index

When was Soleno Therapeutics's last earnings report?

Soleno Therapeutics's most recent earnings report was on Nov 6, 2024

When does Soleno Therapeutics report earnings?

The next expected earnings date for Soleno Therapeutics is Aug 7, 2025

Should I buy Soleno Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions